LSLaura Seikku

Laura Seikku

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Laura Seikku has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Jorma Paavonen

    Faculty of Medicine, University of Helsinki, Helsinki, Finland

    3 shared publications
  • Leena Rahkonen

    Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Finland

    3 shared publications
  • Minna Tikkanen

    Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Finland

    3 shared publications
  • Petri Rahkonen

    Children´s Hospital, Helsinki University Central Hospital, Helsinki, Finland

    3 shared publications
  • Vedran Stefanovic

    Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Finland

    3 shared publications
  • Kari Teramo

    Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Finland

    2 shared publications

Latest Publications

  • Open Access

    Impact of fetal presentation on neurodevelopmental outcome in a trial of preterm vaginal delivery: a nationwide, population-based record linkage study

    by Anna Toijonen, Seppo Heinonen, Mika Gissler, Laura Seikku, Georg Macharey

    Purpose: To assess the risk of adverse neurodevelopmental outcomes at the age of four after an attempted vaginal delivery according to the fetal presentation in birth. Methods: This retrospective record linkage study evaluated the risks of cerebral palsy, epilepsy, intellectual disability, autism spectrum disorder, attention-deficit/hyperactivity disorder, and speech, visual, and auditory disabilities among preterm children born after an attempted vaginal breech delivery. The control group comprised children born in a cephalic presentation at the same gestational age. This study included 23 803 singleton deliveries at gestational weeks 24 + 0–36 + 6 between 2004 and 2014. Results: From 1629 women that underwent a trial of vaginal breech delivery, 1122 (66.3%) were converted to emergency cesarean sections. At extremely preterm and very preterm gestations (weeks 24 + 0—31 + 6), no association between a trial of vaginal breech delivery and neurodevelopmental delay occurred. At gestational weeks 32 + 0—36 + 6, the risks of visual disability (aOR 1.67, CI 1.07—2.60) and autism spectrum disorders (aOR 2.28, CI 1.14—4.56) were increased after an attempted vaginal breech delivery as compared to vaginal cephalic delivery. Conclusion: A trial of vaginal breech delivery at extremely preterm and very preterm gestations appears not to increase the risk of adverse neurodevelopmental outcomes at the age of four. In moderate to late preterm births, a trial of vaginal breech delivery was associated with an increased risk of visual impairment and autism spectrum disorders compared to children born in cephalic presentation. A trial of vaginal preterm breech delivery requires distinctive consideration and careful patient selection.


  • Amniotic fluid and umbilical cord serum erythropoietin in term and prolonged pregnancies

    by Laura Seikku, Vedran Stefanovic, Petri Rahkonen, Kari Teramo, Jorma Paavonen, Minna Tikkanen, Leena Rahkonen


  • Open Access

    Asphyxia, Neurologic Morbidity, and Perinatal Mortality in Early-Term and Postterm Birth

    by Laura Seikku, Mika Gissler, Sture Andersson, Petri Rahkonen, Vedran Stefanovic, Minna Tikkanen, Jorma Paavonen, Leena Rahkonen

    BACKGROUND AND OBJECTIVES: Neonatal outcomes vary by gestational age. We evaluated the association of early-term, full-term, and postterm birth with asphyxia, neurologic morbidity, and perinatal mortality. METHODS: Our register-based study used retrospective data on 214 465 early-term (37+0–38+6 gestational weeks), 859 827 full-term (39+0–41+6), and 55 189 postterm (≥42+0) live-born singletons during 1989–2008 in Finland. Asphyxia parameters were umbilical cord pH and Apgar score at 1 and 5 minutes. Neurologic morbidity outcome measures were cerebral palsy (CP), epilepsy, intellectual disability, and sensorineural defects diagnosed by the age of 4 years. Newborns with major congenital anomalies were excluded from perinatal deaths. RESULTS: Multivariate analysis showed that, compared with full-term pregnancies, early-term birth increased the risk for low Apgar score (<4) at 1 and 5 minutes (odds ratio 1.03, 95% confidence interval 1.03–1.04 and 1.24, 1.04–1.49, respectively), CP (1.40, 1.27–1.55), epilepsy (1.14, 1.06–1.23), intellectual disability (1.39, 1.27–1.53), sensorineural defects (1.24, 1.17–1.31), and perinatal mortality (2.40, 2.14–2.69), but risk for low umbilical artery pH ≤7.10 was decreased (0.83, 0.79–0.87). Postterm birth increased the risk for low Apgar score (<4) at 1 minute (1.26, 1.26–1.26) and 5 minutes (1.80, 1.43–2.34), low umbilical artery pH ≤7.10 (1.26, 1.19–1.34), and intellectual disability (1.19, 1.00–1.43), whereas risks for CP (1.03, 0.84–1.26), epilepsy (1.00, 0.87–1.15), sensorineural defects (0.96, 0.86–1.07), and perinatal mortality (0.91, 0.69–1.22) were not increased. CONCLUSIONS: Early-term birth was associated with low Apgar score, increased neurologic morbidity, and perinatal mortality. Asphyxia and intellectual disability were more common among postterm births, but general neurologic morbidity and perinatal mortality were not increased.


  • Amniotic fluid erythropoietin and neonatal outcome in pregnancies complicated by intrauterine growth restriction before 34 gestational weeks

    by Laura Seikku, Leena Rahkonen, Minna Tikkanen, Esa Hämäläinen, Petri Rahkonen, Sture Andersson, Kari Teramo, Jorma Paavonen, Vedran Stefanovic

    Objective: High amniotic fluid erythropoietin concentration reflects chronic fetal hypoxia. Our aim was to study amniotic fluid erythropoietin concentration in relation to neonatal outcome in pregnancies complicated by intrauterine growth restriction.Design: Retrospective case series.Setting: Helsinki University Hospital, Finland.Sample: A total of 66 singleton pregnancies complicated by intrauterine growth restriction.Methods: Amniocentesis or amniotic fluid sampling at cesarean section was performed between 24 and 34 gestational weeks. Values of amniotic fluid erythropoietin were quantitated with immunochemiluminometric assay. Normal amniotic fluid erythropoietin was defined as 27 IU/L.Main outcome measures: Adverse neonatal outcome.Results: Abnormal biophysical profile and reversed end‐diastolic flow in umbilical artery were associated with abnormal amniotic fluid erythropoietin (p < 0.001 and p = 0.042, respectively). Abnormal amniotic fluid erythropoietin was not associated with absent end‐diastolic flow in umbilical artery or with oligohydramnios (p = 0.404 and p = 0.080, respectively). Decreased umbilical artery pH and base excess values were associated with abnormal amniotic fluid erythropoietin (p = 0.027 and p = 0.007, respectively). Composite adverse neonatal outcome defined as intraventricular hemorrhage, periventricular leukomalacia, cerebral infarction and/or necrotizing enterocolitis was associated with abnormal amniotic fluid erythropoietin (p < 0.001).Conclusions: High amniotic fluid erythropoietin concentrations are associated with decreased umbilical artery pH and base excess and with adverse neonatal outcome in pregnancies complicated by intrauterine growth restriction before 34 gestational weeks. In selected pregnancies complicated by intrauterine growth restriction, determining amniotic fluid erythropoietin could be a useful additional tool in fetal surveillance and possibly in optimizing timing of delivery.